España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Edgewise Therapeutics
EWTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$30.78
-0.02
-0.06%
At close: -
$30.78
0.00050
0.00%
After Hours: Dec 20, 4:01 PM EDT
Get Report
Comment
Edgewise Therapeutics (EWTX) Forecast
News
Earnings
Edgewise Therapeutics (EWTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Edgewise Therapeutics (NASDAQ:EWTX) Stock
Edgewise Therapeutics Stock (NASDAQ: EWTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 17, 2024
Evercore ISI Group Maintains Outperform on Ed...
Benzinga Newsdesk
Monday, December 16, 2024
Tesla, Micron, Broadcom, MARA Holdings And Other Big Stocks Moving Higher On Monday
Avi Kapoor
Edgewise Therapeutics' Lead Candidate Reduces Biomarker Levels In Mid-Stage Study In Patients With Muscle Weakness Disease
Vandana Singh
Edgewise Therapeutics shares are trading high...
Benzinga Newsdesk
Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Edgewise Therapeutics Reports Topline Results...
Benzinga Newsdesk
Wednesday, November 27, 2024
Truist Securities Maintains Buy on Edgewise T...
Benzinga Newsdesk
Friday, November 22, 2024
Evercore ISI Group Initiates Coverage On Edge...
Benzinga Newsdesk
Friday, November 08, 2024
Wedbush Maintains Outperform on Edgewise Ther...
Benzinga Newsdesk
Thursday, November 07, 2024
Edgewise Therapeutics shares are trading lowe...
Benzinga Newsdesk
Edgewise Therapeutics Q3 EPS $(0.36) Beats $(...
Benzinga Newsdesk
Wednesday, October 16, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Friday, October 11, 2024
Piper Sandler Maintains Overweight on Edgewis...
Benzinga Newsdesk
Monday, September 30, 2024
Analysts Think There's Still Time To Get In On Edgewise
MarketBeat
Wednesday, September 25, 2024
Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
MarketBeat
Sunday, September 22, 2024
Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
Lekha Gupta
Friday, September 20, 2024
RBC Capital Maintains Outperform on Edgewise ...
Benzinga Newsdesk
Thursday, September 19, 2024
Crude Oil Gains Over 1%; Mobileye Global Shares Jump
Avi Kapoor
Truist Securities Maintains Buy on Edgewise T...
Benzinga Newsdesk
Dow Jumps Over 500 Points; FactSet Research Posts Upbeat Earnings
Avi Kapoor
Edgewise Therapeutics Stock Shoots Higher On Promising Early Results For Thickened Heart Treatment
Vandana Singh
Darden Restaurants Posts Q1 Results, Joins Tesla, Nvidia, XPeng And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Edgewise Therapeutics shares are trading high...
Benzinga Newsdesk
Market-Moving News for September 19th
Benzinga Newsdesk
Edgewise Therapeutics Announced Top-line Data...
Benzinga Newsdesk
Tuesday, September 17, 2024
Edgewise Therapeutics To Host Webcast Event T...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Edgewise ...
Benzinga Newsdesk
Watching Shares Of Edgewise Therapeutics; Tra...
Benzinga Newsdesk
Friday, August 16, 2024
Wedbush Reiterates Outperform on Edgewise The...
Benzinga Newsdesk
Monday, August 12, 2024
JP Morgan Maintains Overweight on Edgewise Th...
Benzinga Newsdesk
Thursday, August 08, 2024
Edgewise Therapeutics Q2 EPS $(0.34) Beats $(...
Benzinga Newsdesk
Thursday, July 25, 2024
RBC Capital Reiterates Outperform on Edgewise...
Benzinga Newsdesk
Wednesday, July 10, 2024
RBC Capital Reiterates Outperform on Edgewise...
Benzinga Newsdesk
Tuesday, July 09, 2024
Edgewise Therapeutics shares are trading high...
Benzinga Newsdesk
JP Morgan Maintains Overweight on Edgewise Th...
Benzinga Newsdesk
Monday, July 01, 2024
Piper Sandler Maintains Overweight on Edgewis...
Benzinga Newsdesk
Wednesday, June 26, 2024
Wedbush Reiterates Outperform on Edgewise The...
Benzinga Newsdesk
Friday, May 10, 2024
Edgewise Therapeutics Files For Mixed Shelf O...
Benzinga Newsdesk
Thursday, May 09, 2024
Edgewise Therapeutics Q1 EPS $(0.33) Beats $(...
Benzinga Newsdesk
Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
Avi Kapoor
Monday, May 06, 2024
Edgewise Therapeutics Doses First Patient In ...
Benzinga Newsdesk
Tuesday, April 23, 2024
Edgewise Receives EMA Orphan Drug Designation...
Benzinga Newsdesk
Monday, April 22, 2024
RBC Capital Maintains Outperform on Edgewise ...
Benzinga Newsdesk
Wednesday, April 17, 2024
Truist Securities Maintains Buy on Edgewise T...
Benzinga Newsdesk
Tuesday, April 16, 2024
Wedbush Reiterates Outperform on Edgewise The...
Benzinga Newsdesk
Monday, April 15, 2024
Edgewise Therapeutics Reports Two-Year Toplin...
Benzinga Newsdesk
Tuesday, March 12, 2024
RBC Capital Reiterates Outperform on Edgewise...
Benzinga Newsdesk
Thursday, March 07, 2024
Piper Sandler Initiates Coverage On Edgewise ...
Benzinga Newsdesk
Wednesday, February 28, 2024
Edgewise Therapeutics To Present On EDG-5506 ...
Benzinga Newsdesk
Thursday, February 22, 2024
Edgewise Therapeutics: Q4 Earnings Insights
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch